← Back to Search

Other

PH94B Nasal Spray for Social Anxiety Disorder (Palisade-2 Trial)

Phase 3
Waitlist Available
Led By Michael Liebowitz
Research Sponsored by VistaGen Therapeutics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 20 minutes
Awards & highlights

Palisade-2 Trial Summary

This trial is testing a nasal spray to relieve anxiety in people with social anxiety disorder during a public speaking challenge.

Eligible Conditions
  • Social Anxiety Disorder

Palisade-2 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~20 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 20 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Subjective Units of Distress Scale (SUDS)
Secondary outcome measures
Clinical Global Impression - Improvement

Palisade-2 Trial Design

2Treatment groups
Experimental Treatment
Group I: PlaceboExperimental Treatment1 Intervention
Placebo intranasal spray (100 microliters to each nostril) one time
Group II: PH94BExperimental Treatment1 Intervention
3.2 micrograms PH94B intranasal spray (100 microliters to each nostril) one time
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Placebo Nasal Spray
2006
Completed Phase 3
~3780
PH94B Nasal Spray
2021
Completed Phase 3
~210

Find a Location

Who is running the clinical trial?

VistaGen Therapeutics, Inc.Lead Sponsor
8 Previous Clinical Trials
1,025 Total Patients Enrolled
Michael LiebowitzPrincipal InvestigatorMedical Research Network
1 Previous Clinical Trials
23 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
New York
Florida
Kansas
Other
How old are they?
65+
18 - 65
What site did they apply to?
VistaGen Clinical Site
Other
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria

How responsive is this trial?

Typically responds via
Email
Most responsive sites:
  1. VistaGen Clinical Site: < 48 hours
Average response time
  • < 2 Days
Recent research and studies
clinicaltrials.govStudy
PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge - 2
2021. "PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge - 2". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05011396.
~90 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top